Cosentyx and Estradiol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cosentyx (secukinumab) and Estradiol (estradiol). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Cosentyx and Estradiol. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 187,247 Cosentyx users. Check the latest studies of Cosentyx.

What is Estradiol?

Estradiol has active ingredients of estradiol. It is often used in menopause. eHealthMe is studying from 18,986 Estradiol users. Check the latest studies of Estradiol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

87 people who take Cosentyx and Estradiol together, and have interactions are studied.

Cosentyx and Estradiol drug interactions.

What are the common drug interactions of Cosentyx and Estradiol, by gender? *:

female:

  1. Drug ineffective
  2. Pain
  3. Polyp
  4. Retroperitoneal lymphadenopathy (disease of lymph node between peritoneum and the posterior abdominal wall)
  5. Tumour invasion (starting of tumour)
  6. Arthralgia (joint pain)
  7. Alopecia (absence of hair from areas of the body)
  8. Mobility decreased (ability to move is reduced)
  9. Back pain
  10. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

male:

n/a

What are the common drug interactions of Cosentyx and Estradiol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Alopecia (absence of hair from areas of the body)
  3. Cough
  4. Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful)
  5. Dyspnoea (difficult or laboured respiration)
  6. Enthesopathy (disorder of entheses (bone attachments))
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Rash
  9. Rectal haemorrhage (bleeding from anus)
  10. Spinal osteoarthritis (joint cartilage loss in spine)

40-49:

  1. Asthma
  2. Pain
  3. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  4. Discomfort
  5. Rash
  6. Drug ineffective
  7. Injection site pain
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Vision blurred
  10. Visual impairment

50-59:

  1. Hepatotoxicity (chemical-driven liver damage)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Hypertension (high blood pressure)
  4. Insomnia (sleeplessness)
  5. Joint swelling
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Pneumonia
  8. Pyrexia (fever)
  9. Retinal artery occlusion (blockage of retinal artery)
  10. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

60+:

  1. Vomiting
  2. Drug ineffective
  3. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Drug hypersensitivity
  6. Glaucoma (increased fluid pressure in the eye with vision loss)
  7. Hepatic enzyme increased
  8. Hypertension (high blood pressure)
  9. Insomnia (sleeplessness)
  10. Intestinal polyp (small growths in the bowel with the potential for further growth)

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 46 people, 52.87%
  2. Psoriasis (immune-mediated disease that affects the skin): 22 people, 25.29%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 19 people, 21.84%
  4. Nausea (feeling of having an urge to vomit): 7 people, 8.05%
  5. High Blood Pressure: 7 people, 8.05%
  6. Ankylosing Spondylitis (type of arthritis affecting the spine): 7 people, 8.05%
  7. Pain: 6 people, 6.90%
  8. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Cosentyx and Estradiol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cosentyx and Estradiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Estradiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cosentyx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Estradiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on secukinumab and estradiol (the active ingredients of Cosentyx and Estradiol, respectively), and Cosentyx and Estradiol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: